Robert Daniels
Director & CEO

Robert has successfully guided Elastagen from its early research phases through to the current clinical development of its Elastatherapy™ treatments for the rapidly growing cosmetic and medical dermatology markets.

Prior to joining Elastagen Robert had spent the previous 10 years working across a broad range of the life science industry including contract research, medical devices and therapeutics. He has been successful in raising capital; manageing in- and out- licensing programs; joint venture creation; and, manageing product development programs through to the clinic. Robert’s experience includes University spin-outs through to listed companies; and, he has worked in the UK, Australia and Hong Kong.

Most recently he was VP Asia Pacific for PharmaVentures Ltd, a boutique transaction advisory firm specialising in the life sciences. Prior to that Robert was Chief Commercial Officer at Novathera Ltd where he gained significant domain experience in the regenerative medicine field.

Robert has a PhD from University College London and a Masters in Entrepreneurship and Innovation from the Australian Graduate School of Entrepreneurship.

Read more… Hide this…

Prof Tony Weiss
Founder & Consultant Scientist

Professor Tony Weiss is the world leader in human tropoelastin and Elastin research and its applications. A multiple University prize winner, Fulbright Scholar and learned society medalist, he is the main inventor and scientific expert behind the Intellectual Property licensed by Elastagen from the University of Sydney.

He established the leading international human tropoelastin research laboratory which for over the past 15 years has significantly increased our understanding of the expression, handling and applications of human tropoelastin. His lab was the first to construct a synthetic gene capable of large scale production of the full-length human tropoelastin protein. His various chair roles include the USA Gordon Research Conference on Elastin and the Elastic Fiber, university Molecular Biotechnology Program and the Australian Research Council College of Experts biology and biotechnology panel.

He has been a Visiting Professor at multiple universities overseas, holds honorary appointments in Cardiology and Molecular & Clinical Genetics and serves on biomaterials and bionanoscience editorial boards. The University of Sydney recognized his achievements by awarding him a Personal Professorial Chair.

Read more… Hide this…